|
| Protein Name | Heat Shock Protein 10 (Hsp10) |
| Gene | [HSPE1](/genes/hspe1) |
| UniProt | P61604 |
| Molecular Weight | ~10.9 kDa (nonamer) |
| Subcellular Localization | Mitochondria, Cytoplasm |
| Protein Family | Hsp10 co-chaperone family |
| Aliases | HSP10, C1orf147, GroES |
Heat Shock Protein 10 (Hsp10), encoded by the HSPE1 gene, is a mitochondrial co-chaperone that plays essential roles in protein folding, mitochondrial function, and cellular stress responses. Originally discovered as the bacterial GroES homolog, Hsp10 functions as a co-chaperone with HSP70 proteins to facilitate proper protein folding in mitochondria. Growing evidence suggests that Hsp10 is critically involved in neurodegenerative disease mechanisms, particularly in Alzheimer's disease and Parkinson's disease.
The HSPE1 protein forms a characteristic heptameric ring structure (seven subunits), each approximately 10.9 kDa in size. This donut-shaped oligomer provides the folding chamber for the mitochondrial HSP70 (mortalin/mtHsp70). The protein contains:
- N-terminal β-sheet domain involved in oligomerization
- Flexible lid region that covers the central cavity
- Co-chaperone binding site for interaction with HSP70
The structure is highly conserved across eukaryotes, reflecting its essential role in mitochondrial protein quality control.
Hsp10 serves as the co-chaperone for mitochondrial HSP70 (also known as mortalin or Grp75). The Hsp10-Hsp70 complex:
- Facilitates folding of nuclear-encoded mitochondrial proteins
- Prevents aggregation of misfolded proteins in the mitochondrial matrix
- Assists in protein translocation across mitochondrial membranes
As a heat shock protein, Hsp10 is upregulated during cellular stress:
- Oxidative stress response
- Metabolic stress
- Proteotoxic stress
Hsp10 has been implicated in immune modulation and inflammatory responses, with roles in:
- T-cell activation
- Cytokine regulation
- Anti-inflammatory signaling
In Alzheimer's disease, Hsp10 appears to play a protective role:
- Amyloid-β clearance: Hsp10 has been shown to interact with amyloid-beta plaques and may facilitate their clearance [1]
- Mitochondrial protection: By maintaining mitochondrial protein folding, Hsp10 helps protect neurons from amyloid-β-induced mitochondrial dysfunction [2]
- Tau pathology: Some studies suggest Hsp10 may interact with tau pathology, though this relationship is less characterized
Hsp10 shows particular promise in Parkinson's disease research:
- α-Synuclein aggregation: Hsp10 can inhibit α-synuclein alpha-synuclein aggregation, a key pathological feature of PD [3]
- Mitochondrial quality control: Given the central role of mitochondrial dysfunction in PD, Hsp10's mitochondrial chaperone function is particularly relevant
- Neuroprotection: Studies show Hsp10 can protect dopaminergic neurons from various insults [4]
- Amyotrophic Lateral Sclerosis (ALS): Hsp10 may have protective roles in motor neuron disease
- Huntington's Disease: Involvement in mutant huntingtin Huntingtin aggregation clearance
- Prion Diseases: Potential role in prion protein folding
Hsp10 represents a promising therapeutic target:
Pharmacological upregulation of Hsp10 expression using small molecules is being explored:
- Geranylgeranylacetone (GGA) induces Hsp10 expression
- 15-deoxy-Δ12,14-prostaglandin J2 (15d-PGJ2) activates Hsp10
Gene therapy to increase Hsp10 expression is being investigated:
- AAV-mediated Hsp10 delivery in animal models
- CRISPR-based approaches to enhance Hsp10 expression
Hsp10-based combination therapies with other chaperones (e.g., HSP70) are being explored for enhanced neuroprotection.
Key research developments:
- Hsp10 levels are altered in various neurodegenerative disease brains
- Hsp10 can cross the blood-brain barrier, making it therapeutically accessible
- Mitochondrial Hsp10/Hsp70 machinery declines with aging, potentially contributing to age-related neurodegeneration